The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABSCI CORPORATION COM 00091E109   2,101,000 550,000 SH   SOLE   550,000 0 0
AMYLYX PHARMACEUTICALS INC COM 03237H101   1,053,000 325,000 SH   SOLE   325,000 0 0
ANNEXON INC COM 03589W102   3,848,000 650,000 SH   SOLE   650,000 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106   1,874,600 65,000 SH   SOLE   65,000 0 0
ARVINAS INC COM 04335A105   3,571,350 145,000 SH   SOLE   145,000 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   7,838,775 52,500 SH   SOLE   52,500 0 0
ATYR PHARMA INC COM NEW 002120202   1,408,000 800,000 SH   SOLE   800,000 0 0
AXSOME THERAPEUTICS INC COM 05464T104   12,132,450 135,000 SH   SOLE   135,000 0 0
BIOHAVEN LTD CALL G1110E907   17,428,437 348,778 SH   SOLE   348,778 0 0
BLUEPRINT MEDICINES CORP COM 09627Y109   12,950,000 140,000 SH   SOLE   140,000 0 0
BRIDGEBIO PHARMA INC COM 10806X102   4,455,500 175,000 SH   SOLE   175,000 0 0
CAPRICOR THERAPEUTICS INC COM NEW 14070B309   1,901,250 125,000 SH   SOLE   125,000 0 0
CG ONCOLOGY INC COM 156944100   9,432,500 250,000 SH   SOLE   250,000 0 0
CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301   3,300,800 160,000 SH   SOLE   160,000 0 0
CORBUS PHARMACEUTICALS HLDGS COM NEW 21833P301   4,538,600 220,000 SH Put SOLE   220,000 0 0
CORVUS PHARMACEUTICALS INC COM 221015100   2,640,000 500,000 SH   SOLE   500,000 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   7,665,000 150,000 SH   SOLE   150,000 0 0
DYNE THERAPEUTICS INC COM 26818M108   3,592,000 100,000 SH   SOLE   100,000 0 0
EDGEWISE THERAPEUTICS INC COM 28036F105   5,204,550 195,000 SH   SOLE   195,000 0 0
ENGENE HOLDINGS INC COM 29286M105   1,061,927 160,898 SH   SOLE   160,898 0 0
HELIX ACQUISITION CORP II CL A ORD SHS G4444H101   3,134,988 300,000 SH   SOLE   300,000 0 0
IMMUNOVANT INC COM 45258J102   6,129,650 215,000 SH   SOLE   215,000 0 0
INSMED INC COM PAR $.01 457669307   5,475,000 75,000 SH   SOLE   75,000 0 0
INSMED INC COM PAR $.01 457669307   3,650,000 50,000 SH Call SOLE   50,000 0 0
JANUX THERAPEUTICS INC COM 47103J105   8,631,700 190,000 SH   SOLE   190,000 0 0
KORRO BIO INC COM 500946108   3,676,200 110,000 SH   SOLE   110,000 0 0
LARIMAR THERAPEUTICS INC COM 517125100   1,310,000 200,000 SH   SOLE   200,000 0 0
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104   6,474,483 128,411 SH   SOLE   128,411 0 0
NEUROGENE INC COM 64135M105   2,098,000 50,000 SH   SOLE   50,000 0 0
NOVO-NORDISK A S ADR 670100205   13,097,700 110,000 SH   SOLE   110,000 0 0
NUVATION BIO INC COM CL A 67080N101   3,091,500 1,350,000 SH   SOLE   1,350,000 0 0
OLEMA PHARMACEUTICALS INC COM 68062P106   6,387,900 535,000 SH   SOLE   535,000 0 0
PERSPECTIVE THERAPEUTICS INC COM NEW 46489V302   10,012,500 750,000 SH   SOLE   750,000 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107   6,780,000 375,000 SH   SOLE   375,000 0 0
PROQR THRAPEUTICS N V SHS EURO N71542109   1,615,614 887,700 SH   SOLE   887,700 0 0
REGENXBIO INC COM 75901B107   2,779,850 265,000 SH   SOLE   265,000 0 0
REPLIMUNE GROUP INC COM 76029N106   4,932,000 450,000 SH   SOLE   450,000 0 0
REZOLUTE INC COM NEW 76200L309   7,153,726 1,474,995 SH   SOLE   1,474,995 0 0
RHYTHM PHARMACEUTICALS INC COM 76243J105   4,130,532 78,842 SH   SOLE   78,842 0 0
ROIVANT SCIENCES LTD SHS G76279101   9,232,000 800,000 SH   SOLE   800,000 0 0
SAREPTA THERAPEUTICS INC COM 803607100   14,986,800 120,000 SH   SOLE   120,000 0 0
SAVARA INC COM 805111101   3,074,000 725,000 SH   SOLE   725,000 0 0
SOLENO THERAPEUTICS INC COM 834203309   7,573,500 150,000 SH   SOLE   150,000 0 0
SPDR SER TR S&P BIOTECH 78464A870   29,640,000 300,000 SH Put SOLE   300,000 0 0
SPYRE THERAPEUTICS INC COM NEW 00773J202   1,764,600 60,000 SH   SOLE   60,000 0 0
SUMMIT THERAPEUTICS INC COM 86627T108   1,861,500 85,000 SH   SOLE   85,000 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105   8,662,500 450,000 SH   SOLE   450,000 0 0
TARSUS PHARMACEUTICALS INC COM 87650L103   11,511,500 350,000 SH   SOLE   350,000 0 0
TAYSHA GENE THERAPIES INC COM SHS 877619106   4,321,500 2,150,000 SH   SOLE   2,150,000 0 0
TENAYA THERAPEUTICS INC COM 87990A106   2,895,000 1,500,000 SH   SOLE   1,500,000 0 0
TG THERAPEUTICS INC COM 88322Q108   7,250,900 310,000 SH   SOLE   310,000 0 0
VAXCYTE INC COM 92243G108   9,141,600 80,000 SH   SOLE   80,000 0 0
VIKING THERAPEUTICS INC COM 92686J106   8,863,400 140,000 SH   SOLE   140,000 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   1,706,250 75,000 SH   SOLE   75,000 0 0